ELEVATED LEVELS OF CHEMOTAXIS INHIBITORY ACTIVITY IN SERA OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

E-ISSN： 1346-8138|7|5|309-315

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.7, Iss.5, 1980-10, pp. : 309-315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated serum interleukin‐35 is associated with disease activity in patients with systemic lupus erythematosus

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 12, 2017-12 ,pp. : 2154-2156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus

ARTHRITIS & RHEUMATOLOGY, Vol. 70, Iss. 2, 2018-02 ,pp. : 266-276

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus

By Reddy Venkat

British Journal of Rheumatology , Vol. 52, Iss. 5, 2013-05 ,pp. : 951-952

Oxford University Press

Access to resources Recommend Favorite

Increased Insulin Resistance and Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients Despite Normal Glucose Tolerance

ARTHRITIS CARE AND RESEARCH, Vol. 70, Iss. 1, 2018-01 ,pp. : 114-124

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of BLyS on the activity of peripheral B lymphocytes mediated by BLyS receptors in patients with systemic lupus erythematosus

By Cheng Yan

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, Iss. 2, 2013-03 ,pp. : 141-147

Informa Healthcare

Access to resources Recommend Favorite